Literature DB >> 6966764

The effects of 5-HT uptake- and MAO-inhibitors on L-5-HTP-induced excitation in rats.

R Ortmann, P C Waldmeier, E Radeke, A Felner, A Delini-Stula.   

Abstract

The behavioural syndrome caused by L-5-HTP in rats was used for the study of effects of selective 5-HT uptake inhibitors and inhibitors of MAO on central 5-HT receptors. A good correlation was found between the relative potencies of drugs in inhibiting the 5-HT uptake in the rat brain and in intensifying L-5-HTP-induced behavioural stimulation. The potentiation of the L-5-HTP syndrome by the MAO inhibitors correlated with the inhibition of the A- but not of the B-form of the brain monoamine oxidase. In rats treated with the maximally inhibiting dose of a 5-HT uptake inhibitor, MAO inhibitors were still able to increase the intensity of the L-5-HTP syndrome, while the combination of maximal doses of two 5-HT uptake inhibitors did not produce a more intense syndrome than that produced by one 5-HT uptake inhibitor alone. The L-5-HTP-induced behavioural syndrome in rats seems to afford an experimental model allowing the quantification and characterization of the interaction of drugs with serotonin metabolism in the brain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966764     DOI: 10.1007/BF00510258

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Stereotyped hyperactivity in rats treated with tranylcypromine and specific inhibitors of 5-HT reuptake.

Authors:  R B Holman; E Seagraves; G R Elliott; J D Barchas
Journal:  Behav Biol       Date:  1976-04

2.  Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140).

Authors:  R W Fuller; K W Perry; B B Molloy
Journal:  Life Sci       Date:  1974-09-15       Impact factor: 5.037

3.  The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan.

Authors:  C A Marsden; G Curzon
Journal:  Neuropharmacology       Date:  1979-02       Impact factor: 5.250

Review 4.  Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.

Authors:  A R Green; D G Grahame-Smith
Journal:  Nature       Date:  1976-04-08       Impact factor: 49.962

5.  Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.

Authors:  P C Waldmeier; L Maître
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

6.  Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.

Authors:  A R Green; M B Youdim
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

7.  Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.

Authors:  P C Waldmeier; P A Baumann; M Wilhelm; R Bernasconi; L Maître
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432

8.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

9.  The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.

Authors:  J F Deakin; A R Green
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  24 in total

Review 1.  Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; A Ward
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 2.  Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

3.  5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.

Authors:  D M Kuhn; W A Wolf; M B Youdim
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Central beta-adrenoceptors can modulate 5-hydroxytryptamine-induced tremor in rats.

Authors:  H Hallberg
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

5.  Supersensitivity to L-5-hydroxytryptophan after 5,7-dihydroxytryptamine injections in desmethylimipramine- and nomifensine-pretreated rats: behavioral evidence for postsynaptic supersensitivity.

Authors:  R Ortmann; S Martin; P C Waldmeier
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome.

Authors:  R Ortmann; S Martin; E Radeke; A Delini-Stula
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

7.  Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors.

Authors:  R Ortmann; M Schaub; A Felner; J Lauber; P Christen; P C Waldmeier
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.

Authors:  M K Mundey; A Fletcher; C A Marsden
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.

Authors:  R Ashkenazi; J P Finberg; M B Youdim
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

10.  Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; E Mogilnicka; A Delini-Stula; F Waechter; A Truog; J Wood
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.